History of myeloid-derived suppressor cells
Open accessThe DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
Abstract
Tumour-induced granulocytic hyperplasia is associated with tumour vasculogenesis and escape from immunity via T cell suppression. Initially, these myeloid cells were identified as granulocytes or monocytes; however, recent studies have revealed that this hyperplasia is associated with populations of multipotent progenitor cells that have been identified as myeloid-derived suppressor cells (MDSCs). The study of MDSCs has provided a wealth of information regarding tumour pathobiology, has extended our understanding of neoplastic progression and has modified our approaches to immune adjuvant therapy. In this Timeline article, we discuss the history of MDSCs, their influence on tumour progression and metastasis, and the crosstalk between tumour cells, MDSCs and the host macroenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Myeloid-derived suppressor cells (MDSCs), a heterogeneous group of immune cells from the myeloid lineage, are a major component of the immunosuppressive TME [93].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [93]
The cited source says what the claim attributes to it.
In the citing paper
“The TME is immunosuppressive, thus rendering the immune system less effective in killing cancer cells.”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Self-citationMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Goycoolea, A. (1997) · Cited by 3,615
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., & Isner, J. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3964 · Cited by 1,856
Research works printed but not linked: 1
- Sonnenfeld A Leukamische reaktiones bei carcinoma Zeitschrift f Klin Med 1929 111
Cited by
Items 601–700 of 1,000
Yu, A., Wang, Y., Yin, J., Zhang, J., Cao, S., Cao, J., & Shen, Y. (2018) · Parasites & Vectors · doi:10.1186/s13071-018-2905-6 · Cited by 31
Gao, M., Huang, A., Sun, Z., Sun, Y. H., Chang, B., Zhang, J., & Zou, Z. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14109 · Cited by 28
Zhang, J., Han, X., Shi, H., Gao, Y., Qiao, X., Li, H., Wei, M., & Zeng, X. (2019) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2019.101498 · Cited by 27
Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease
Kim, Y., Chang, S., & Ko, H. (2015) · Intestinal Research · doi:10.5217/ir.2015.13.2.105 · Cited by 25
Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors
Rajani, K. R., & Vile, R. G. (2015) · Viruses · doi:10.3390/v7112914 · Cited by 26
Relevance of Interferon Regulatory Factor-8 Expression in Myeloid–Tumor Interactions
Abrams, S. I., Netherby, C. S., Twum, D. Y. F., & Messmer, M. N. (2016) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2015.0174 · Cited by 26
The Effect of Immunosuppressive Drugs on MDSCs in Transplantation
Yang, F., Li, Y., Zhang, Q., Tan, L., Peng, L., & Zhao, Y. X. (2018) · Journal of Immunology Research · doi:10.1155/2018/5414808 · Cited by 28
Myeloid-derived suppressor cells in gastrointestinal cancers: A systemic review
Farshidpour, M., Ahmed∥, M., Junna, S., & Merchant, J. L. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i1.1 · Cited by 26
The dual role of complement in cancers, from destroying tumors to promoting tumor development
Lü, P., Ma, Y., Wei, S., & Liang, X. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155522 · Cited by 25
LncRNAs has been identified as regulators of Myeloid-derived suppressor cells in lung cancer
Liu, Y., Han, Y., Zhang, Y., Lv, T., Peng, X., & Huang, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1067520 · Cited by 25
Biomarkers for glioma immunotherapy: the next generation
Sims, J. S., Ung, T. H., Neira, J. A., Canoll, P., & Bruce, J. N. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1746-9 · Cited by 26
Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles
Loskog, A. (2015) · Viruses · doi:10.3390/v7112899 · Cited by 26
Implications of MDSCs-targeting in lung cancer chemo-immunotherapeutics
Adah, D., Hussain, M., Qin, L., Qin, L., Zhang, J., & Chen, X. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.05.007 · Cited by 28
Pharmacological Modulation of Proton Channel Hv1 in Cancer Therapy: Future Perspectives
Fernández, A., Pupo, A., Mena‐Ulecia, K., & Gonzalez, C. L. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.103804 · Cited by 26
Drabczyk-Pluta, M., Werner, T., Hoffmann, D. E., Leng, Q., Chen, L., Dittmer, U., & Zelinskyy, G. (2017) · Retrovirology · doi:10.1186/s12977-017-0364-3 · Cited by 25
Lin, Y., Wang, B., Wei, S., Tan, Y., Feng, J., Xu, L., Wang, L., Han, B., Zhang, M., Yu, J., et al. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.11.005 · Cited by 25
NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma
Yen, C., & Hsiao, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113503 · Cited by 26
Sorrentino, C., Yin, Z., Ciummo, S. L., Lanuti, P., Lu, L., Marchisio, M., Bellone, M., & Carlo, E. D. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0668-z · Cited by 25
PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy
Bocanegra, A., Blanco, E., Fernández-Hinojal, G., Arasanz, H., Chocarro, L., Zuazo, M., Morente, P., Vera, R., Escors, D., & Kochan, G. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165918 · Cited by 25
Direct interaction between CD155 and CD96 promotes immunosuppression in lung adenocarcinoma
He, W., Zhang, H., Lei, Y., Cui, Y., Zhu, Y., Zhu, J., 雷艺炎, Lin, R., Xu, D., Zhu, Z., et al. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00538-y · Cited by 25
Han, Y., Mu, D., Liu, T., Zhang, H., Zhang, J., Li, S., Wang, R., Du, W., Hui, Z., Zhang, X., et al. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13731 · Cited by 25
Research progress of tumor microenvironment and tumor-associated macrophages
Liang, W. H., Huang, X., Carlos, C. J. J., & Lü, X. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02367-x · Cited by 25
The functions of EZH2 in immune cells: Principles for novel immunotherapies
Shao, F.-F., Chen, B.-J., & Wu, G. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ru0520-311r · Cited by 26
Shi, G., Li, D., Zhang, D., Xu, Y., Pan, Y., Lü, L., Li, J., Xia, X., Dou, H., & Hou, Y. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00568-z · Cited by 24
Wang, L., Hu, D., Xie, B., & Xie, L. (2022) · Investigational New Drugs · doi:10.1007/s10637-022-01218-6 · Cited by 24
Angka, L., de Souza, C. T., Baxter, K. E., Khan, S., Market, M., Martel, A. B., Tai, L., Kennedy, M. A., Bell, J. C., & Auer, R. C. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.05.024 · Cited by 24
Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation
van Geffen, C., Heiss, C., Deißler, A., & Kolahian, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.933847 · Cited by 24
Stanojević, I., Miller, K., Sekulović, L. K., Mijušković, Ž. P., Zolotarevski, L. D., Jović, M., Gacevic, M., Djukic, M. M., Arsenijević, N., & Vojvodić, D. (2015) · International Immunology · doi:10.1093/intimm/dxv053 · Cited by 24
Xing, Y., Cai, R., Lin, Q., Ye, Q., Ren, J., Yin, L., & Li, X. (2017) · Kidney International · doi:10.1016/j.kint.2016.12.015 · Cited by 24
Ming, W., Xie, H., Hu, Z., Chen, Y., Zhu, Y., Bai, Y., Liu, H., Sun, X. S., Liu, Y., & Gu, W. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00985 · Cited by 26
Wu, X., Pan, B., Chu, C., Zhang, Y., Ma, J., Yang, X. H., Ma, Y., Zhu, W., Zhong, H., Alimu, A., et al. (2024) · Advanced Science · doi:10.1002/advs.202409537 · Cited by 27
Concise Review: Modulating Cancer Immunity with Hematopoietic Stem and Progenitor Cells
Wildes, T. J., Flores, C. T., & Mitchell, D. A. (2018) · Stem Cells · doi:10.1002/stem.2933 · Cited by 23
A Highlight of the Mechanisms of Immune Checkpoint Blocker Resistance
Huang, Q., Lei, Y., Li, X., Guo, F., & Liu, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.580140 · Cited by 25
Zhou, D., Meng, Y., Zhang, L., Chen, Y., He, J., Zhang, Y., Xu, H., Zhou, P., Zhong, W., Yao, Z. Q., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200142 · Cited by 24
Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
Al-Mterin, M. A., & Elkord, E. (2022) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2022.00097 · Cited by 25
Yan, R., Li, J. J., Xiao, Z., Fan, X., Liu, H., Xu, Y., Sun, R., Liu, J., Yao, J., An, G., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.10.013 · Cited by 23
Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more
Shibata, M., Nanno, K., Yoshimori, D., Nakajima, T., Takada, M., Yazawa, T., Mimura, K., Inoue, N., Watanabe, T., Tachibana, K., et al. (2022) · Oncotarget · doi:10.18632/oncotarget.28303 · Cited by 25
The role of metabolic reprogramming in immune escape of triple-negative breast cancer
Bao, R., Qu, H., Li, B., Cheng, K., Miao, Y., & Wang, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1424237 · Cited by 23
Aghaeepour, N., Kin, C., Ganio, E. A., Jensen, K. P., Gaudilliere, D. K., Tingle, M. S., Tsai, A. S., Lancero, H. L., Choisy, B., McNeil, L. S., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700421 · Cited by 23
MiR‐486 promotes proliferation and suppresses apoptosis in myeloid cells by targeting Cebpa in vitro
Jiang, J., Gao, Q., Gong, Y., Huang, L., Lin, H., Zhou, X., Liang, X., & Guo, W. (2018) · Cancer Medicine · doi:10.1002/cam4.1694 · Cited by 23
The challenges of checkpoint inhibition in the treatment of multiple myeloma
Paul, B. A., Kang, S., Zheng, Z., & Kang, Y. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.10.003 · Cited by 24
Simon, N. C., Antignani, A., Hewitt, S. M., Gadina, M., Alewine, C., & FitzGerald, D. J. (2019) · JCI Insight · doi:10.1172/jci.insight.123281 · Cited by 23
Fu, S., Chen, G. T. Y., Wang, C., Yu, C., Chiang, C., & Hong, J. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.11.004 · Cited by 25
Sun, Y., Li, Z., Wang, W., Zhang, X., Li, W., Du, G., Yin, J., Xiao, W., & Yang, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.957865 · Cited by 23
Immunomodulatory nanoparticles ameliorate disease in the Leishmania (Viannia) panamensis mouse model
Siefert, A. L., Ehrlich, A. K., Corral, M. J., Goldsmith‐Pestana, K., McMahon‐Pratt, D., & Fahmy, T. M. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.004 · Cited by 25
Wu, G., Huang, F., Chen, Y., Zhuang, Y., Huang, Y., & Xie, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00194 · Cited by 22
Metallic nanomedicine in cancer immunotherapy
Li, S., Wang, X., Han, H., Xiang, S., Li, M., Long, G., Xia, Y., Zhang, Q., & Li, S. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.017 · Cited by 22
Zheng, X., Zhou, Y., Yi, X., Chen, C., Wen, C., Ye, G., Li, X., Tang, L., Zhang, X., Yang, F., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1500673 · Cited by 24
Kun, Z., Xin, G., Tao, W., Chenglong, Z., Dongsheng, W., Tang, L., Liu, T., & Xiao, J. (2019) · Journal of bone oncology · doi:10.1016/j.jbo.2019.100238 · Cited by 23
Orthopaedic Surgery Elicits a Systemic Anti-Inflammatory Signature
Heim, C. E., Yamada, K. J., Fallet, R. W., Odvody, J., Schwarz, D. M., Lyden, E. R., Anderson, M. J., Alter, R., Vidlak, D., Hartman, C. W., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072123 · Cited by 22
G-CSF promotes alloregulatory function of MDSCs through a c-Kit dependent mechanism
Lee, Y. S., Saxena, V., Bromberg, J. S., & Scalea, J. R. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104346 · Cited by 22
Role of T Regulatory Cells and Myeloid-Derived Suppressor Cells in COVID-19
Alsalman, A., Al-Mterin, M. A., & Elkord, E. (2022) · Journal of Immunology Research · doi:10.1155/2022/5545319 · Cited by 26
Nanoparticle-mediated metronomic chemotherapy in cancer: A paradigm of precision and persistence
Kirti, A., Simnani, F. Z., Jena, S., Lenka, S. S., Kalalpitiya, C., Naser, S. S., Singh, D., Choudhury, A., Sahu, R. N., Yadav, A., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216990 · Cited by 22
Bandyopadhyay, S., Bhattacharjee, A., Banerjee, S., Halder, K., Das, S., Chowdhury, B. P., & Majumdar, S. (2015) · Infection and Immunity · doi:10.1128/iai.00729-15 · Cited by 22
Asakura, T., Ishii, M., Namkoong, H., Suzuki, S., Kagawa, S., Yagi, K., Komiya, T., Hashimoto, T., Okamori, S., Kamata, H., et al. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0077-5 · Cited by 22
Shi, G., Li, D., Li, X., Ren, J., Xu, J., Ding, L., Dou, H., & Hou, Y. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.007 · Cited by 22
Suzuki, E., Sugimoto, M., Kawaguchi, K., Pu, F., Uozumi, R., Yamaguchi, A., Nishie, M., Tsuda, M., Kotake, T., Morita, S., et al. (2018) · Breast Cancer · doi:10.1007/s12282-018-0920-2 · Cited by 22
Ma, Z., Xia, Y., Hu, C., Yu, M., & Yi, H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109922 · Cited by 22
Neutrophils in cancer—unresolved questions
Ng, M. S. F., Tan, L., Wang, Q., Mackay, C. R., & Ng, L. G. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1853-4 · Cited by 22
Panahi, H. K. S., Dehhaghi, M., Lam, S. S., Peng, W., Aghbashlo, M., Tabatabaei, M., & Guillemin, G. J. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.013 · Cited by 22
Saddawi‐Konefka, R., Simon, A. B., Sumner, W., Sharabi, A. B., Mell, L. K., & Cohen, E. E. W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.738626 · Cited by 22
Regulation of plasmacytoid dendritic cell development in mice by aryl hydrocarbon receptor
Liu, H., Ramachandran, I., & Gabrilovich, D. I. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.65 · Cited by 22
Self-citationHong, H. S., Koch, S. D., Scheel, B., Gnad-Vogt, U., Schröder, A., Kallen, K., Wiegand, V., Backert, L., Kohlbacher, O., Hoerr, I., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1249560 · Cited by 22
Alberca, R. W., Andrade, M. M. D. S., Branco, A. C. C. C., Pietrobon, A. J., Pereira, N. Z., Fernandes, I. G., Oliveira, L. D. M., Teixeira, F. M. E., Beserra, D. R., de Oliveira, E. A., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.580677 · Cited by 21
Cui, H., Lan, Z., Zou, K., Zhao, Y., & Yu, G. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03336-9 · Cited by 21
Xia, B., Liu, Y., Wang, J., Lu, Q., Lv, X., Deng, K., & Yang, J. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106880 · Cited by 21
Extracellular vesicles mediated gastric cancer immune response: tumor cell death or immune escape?
Yang, S., Wei, S., & Wei, F. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06758-8 · Cited by 21
Myeloid-derived suppressor cells exacerbate Sjögren’s syndrome by inhibiting Th2 immune responses
Qi, J., Li, D., Shi, G., Zhang, B., Pan, Y., Dou, H., Yao, G., & Hou, Y. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.07.016 · Cited by 21
Liu, B.-Q., Bao, Z., Zhu, J.-Y., & Liu, H. (2020) · Oncology Letters · doi:10.3892/ol.2020.12308 · Cited by 21
Wang, B., He, Z., Yu, H., Ou, Z., Chen, J., Yang, M., Fan, X., Lin, T., & Huang, J. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-03063-7 · Cited by 21
Raineri, D., Cappellano, G., Vilardo, B., Maione, F., Clemente, N., Canciani, E., Boggio, E. M., Gigliotti, C. L., Monge, C., Dianzani, C., et al. (2021) · Biomedicines · doi:10.3390/biomedicines10010051 · Cited by 22
Wang, J., McGuire, T. R., Britton, H. C., Schwarz, J. K., Loberiza, F. R., Meza, J. L., & Talmadge, J. E. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9696-3 · Cited by 21
Self-citationDeronic, A., Tahvili, S., Leanderson, T., & Ivars, F. (2016) · BMC Cancer · doi:10.1186/s12885-016-2481-0 · Cited by 21
Pilátová, K., Bencsiková, B., Demlová, R., Valík, D., & Dubská, L. Z. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2166-4 · Cited by 21
Wu, L., Xu, Y., Zhao, H., Zhou, Y. J., Chen, Y., Yang, S., Lei, J., Zhang, J., Wang, J., Wu, Y., et al. (2021) · Theranostics · doi:10.7150/thno.66575 · Cited by 20
The paradoxical role of MDSCs in inflammatory bowel diseases: From bench to bedside
Zhao, F., Gong, W., Song, J., Shen, Z., & Cui, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1021634 · Cited by 21
Dendritic cell vaccine of gliomas: challenges from bench to bed
Zheng, Y., Ma, X., Feng, S., Zhu, H., Chen, X., Yu, X., Shu, K., & Zhang, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1259562 · Cited by 22
Feng, L., Li, M., Ma, J., Wang, W., Wang, S., Mao, Z., & Zhang, Y. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.03.003 · Cited by 20
Comparing thermal stress reduction strategies that influence MDSC accumulation in tumor bearing mice
MacDonald, C. R., Ministero, S., Pandey, M. R., Robinson, D. L., Hong, E. F., Hylander, B. L., McCarthy, P. L., Gordon, C. J., Repasky, E. A., & Mohammadpour, H. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104285 · Cited by 20
Suppressive Myeloid Cells Shape the Tumor Immune Microenvironment
Xiong, J., Wang, H., & Wang, Q. (2021) · Advanced Biology · doi:10.1002/adbi.201900311 · Cited by 21
Hypoxia and its impact on the tumour microenvironment of gastroesophageal cancers
King, R., Hayes, C., Donohoe, C. L., Dunne, M. R., Davern, M., & Donlon, N. E. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i5.312 · Cited by 25
Dong, S., Shah, N. K., He, J., Han, S., Xie, M., Wang, Y., Cheng, T., Liu, Z., & Shu, C. (2021) · Placenta · doi:10.1016/j.placenta.2021.08.060 · Cited by 20
Rosenbaum, P., Tchitchek, N., Joly, C., Stimmer, L., Hocini, H., Dereuddre‐Bosquet, N., Beignon, A., Chapon, C., Lévy, Y., Grand, R. L., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00870 · Cited by 21
Liu, Y., Jiang, X., Zhuang, S., Zhu, L., Zhu, B., Rui, K., & Tian, J. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103885 · Cited by 22
A promising target for breast cancer: B7-H3
Jiang, Y., Liu, J., Chen, L., Qian, Z., & Zhang, Y. (2024) · BMC Cancer · doi:10.1186/s12885-024-11933-3 · Cited by 20
Chen, J., Zhu, H., Chen, S., & Mi, H. (2024) · OncoTargets and Therapy · doi:10.2147/ott.s447319 · Cited by 19
Hernández‐González, F., Pietrocola, F., Cameli, P., Bargagli, E., Prieto‐González, S., Cruz, T., Mendoza, N., Rojas, M. M., Serrano, M., Agustí, A. G. N., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147554 · Cited by 19
Regulation of immunity by Taeniids: lessons from animal models and in vitro studies
Peón, A. N., Ledesma‐Soto, Y., & Terrazas, L. I. (2015) · Parasite Immunology · doi:10.1111/pim.12289 · Cited by 19
Abedi‐Valugerdi, M., Wolfsberger, J., Pillai, P. R., Zheng, W., Sadeghi, B., Zhao, Y. H., & Hassan, M. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.08.023 · Cited by 19
Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders
Barnie, P. A., Zhang, P., Lv, H., Wang, D., Su, X., Su, Z., & Xu, H. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.4018 · Cited by 19
Hassan, M., Raslan, H. M., Eldin, H. G., Mahmoud, E., & Elwajed, H. A.-E. A. (2018) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2018.080 · Cited by 20
Yamamoto, T., Kosaka, N., Hattori, Y., & Ochiya, T. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7030055 · Cited by 21
The interplay between neutrophils and microbiota in cancer
Smith, C. K., & Trinchieri, G. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ri0418-151r · Cited by 21
Agrati, C., Tumino, N., Bordoni, V., Pinnetti, C., Sabatini, A., Amendola, A., Abbate, I., Lorenzini, P., Mondi, A., Casetti, R., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01886 · Cited by 19
Drug resistance in cancer immunotherapy: new strategies to improve checkpoint inhibitor therapies
Rodríguez-Pascual, J., Ayuso‐Sacido, Á., & Belda-Iniesta, C. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.61 · Cited by 21
Organotypic Modeling of the Tumor Landscape
Haykal, M. M., Nahmias, C., Varon, C., & Martin, O. C. B. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.606039 · Cited by 19
Myeloid-Derived Suppressor Cells (MDSCs) and the Immunoinflammatory Response to Injury (Mini Review)
Sayyadioskoie, S., & Schwacha, M. G. (2021) · Shock · doi:10.1097/shk.0000000000001795 · Cited by 19
A robust blood gene expression-based prognostic model for castration-resistant prostate cancer
Wang, L., Gong, Y., Chippada-Venkata, U., Heck, M. M., Retz, M. M., Nawroth, R., Galsky, M. D., Tsao, C., Schadt, E. E., Bono, J. S. D., et al. (2015) · BMC Medicine · doi:10.1186/s12916-015-0442-0 · Cited by 20
Blood-based analyses of cancer: Circulating myeloid-derived suppressor cells – is a new era coming?
Okła, K., Wertel, I., Wawruszak, A., Bobiński, M. S., & Kotarski, J. (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1477729 · Cited by 20
Mathematical Analysis of Cytokine-Induced Differentiation of Granulocyte-Monocyte Progenitor Cells
Weston, B. R., Li, L., & Tyson, J. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02048 · Cited by 19
Metadata
- Authors
- Talmadge, J. E., & Gabrilovich, D. I.
- Affiliations
- University of Nebraska Medical Center (US)
- The Wistar Institute (US)
- Corresponding author
- Talmadge, James E.
- Venue
- Nature Reviews Cancer
- Published
- 2013-09-24
- Volume
- 13
- Issue
- 10
- Pages
- 739-752
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC4358792
- OpenAlex
- W2122403898
- Cited by
- 1,148
- References
- 197
- Citations by year
- 2026: 29 · 2025: 57 · 2024: 80 · 2023: 74 · 2022: 105 · 2021: 132 · 2020: 110 · 2019: 95 · 2018: 101 · 2017: 90 · 2016: 129 · 2015: 93 · 2014: 43 · 2013: 7
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA084488, R01CA100062)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- myeloid-derived suppressor cells, tumor microenvironment, T cell suppression, immune evasion, tumor progression, metastasis, multipotent progenitors
- MeSH terms
- Animals, Antigens, Differentiation, Antigens, Neoplasm, Cell Differentiation, Cell Biology, Hematopoiesis, Extramedullary, Humans, Leukemoid Reaction, Medical Oncology, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Chemokines, Cell Lineage, Tumor Escape, Hematopoietic Stem Cell Mobilization, Myeloid Cells, Myeloid Progenitor Cells, Multipotent Stem Cells, Tumor Burden, History, 20th Century, History, 21st Century, Mice, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.